NCT02424370View on ClinicalTrials.gov

Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation

CompletedOBSERVATIONAL
Enrollment

515

Participants

Timeline

Start Date

December 9, 2015

Primary Completion Date

September 18, 2018

Study Completion Date

January 23, 2020

Conditions
Symptomatic Aortic Stenosis
Interventions
PROCEDURE

TAVR

Percutaneous aortic valve replacement

Trial Locations (1)

75013

Institut de Cardiologie-GH Pitié Salpétirère, Paris

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02424370 - Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation | Biotech Hunter | Biotech Hunter